TFG Asset Management GP Ltd 13F 持仓 · 2026年Q2
TFG Asset Management GP 在 2026年Q2（报告期截至 2026-06-30）的 SEC 13F 申报中报告了 32 只证券，申报市值合计 6.35 亿美元。前几大持仓：PATH（52.98%）、KGEI（5.33%）、AUTL（2.39%）。本季前 25 大持仓中：新建仓 2 只、增持 13 只、减持 4 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | PATH | UIPATH INC | $336.4M | 52.98% | 30.9M | 增持 |
| 2 | KGEI | KOLIBRI GLOBAL ENERGY INC | $33.8M | 5.33% | 6.8M | 持平 |
| 3 | AUTL | AUTOLUS THERAPEUTICS LTD | $15.2M | 2.39% | 9.5M | 持平 |
| 4 | LYFT | LYFT INC | $14.6M | 2.30% | 1.0M | 持平 |
| 5 | DFTX | DEFINIUM THERAPEUTICS INC | $13.5M | 2.13% | 286,990 | 增持 |
| 6 | WK | WORKIVA INC | $12.1M | 1.91% | 250,000 | 持平 |
| 7 | SLN | SILENCE THERAPEUTICS PLC | $11.7M | 1.84% | 1.1M | 增持 |
| 8 | CXM | SPRINKLR INC | $11.4M | 1.79% | 2.2M | 持平 |
| 9 | MBX | MBX BIOSCIENCES INC | $11.2M | 1.77% | 203,543 | 增持 |
| 10 | ALKT | ALKAMI TECHNOLOGY INC | $10.9M | 1.71% | 600,284 | 新建仓 |
| 11 | CLDX | CELLDEX THERAPEUTICS INC NEW | $10.8M | 1.70% | 290,441 | 减持 |
| 12 | RLAY | RELAY THERAPEUTICS INC | $10.7M | 1.68% | 570,311 | 增持 |
| 13 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $10.6M | 1.67% | 130,484 | 增持 |
| 14 | PHVS | PHARVARIS N V | $10.2M | 1.61% | 295,627 | 增持 |
| 15 | ALKS | ALKERMES PLC | $10.0M | 1.57% | 189,979 | 增持 |
| 16 | IMVT | IMMUNOVANT INC | $9.9M | 1.55% | 255,934 | 增持 |
| 17 | AGIO | AGIOS PHARMACEUTICALS INC | $9.5M | 1.49% | 255,579 | 增持 |
| 18 | AXSM | AXSOME THERAPEUTICS INC. | $8.6M | 1.35% | 35,000 | 减持 |
| 19 | DYN | DYNE THERAPEUTICS INC | $7.9M | 1.25% | 356,657 | 增持 |
| 20 | IONS | IONIS PHARMACEUTICALS INC | $7.7M | 1.21% | 97,173 | 增持 |
| 21 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $7.3M | 1.15% | 201,036 | 增持 |
| 22 | KRYS | KRYSTAL BIOTECH INC | $7.3M | 1.15% | 19,668 | 持平 |
| 23 | ANNX | ANNEXON INC | $7.1M | 1.12% | 1.2M | 减持 |
| 24 | CELC | CELCUITY INC | $6.7M | 1.06% | 64,110 | 新建仓 |
| 25 | WBD | WARNER BROS DISCOVERY INC | $6.7M | 1.05% | 250,000 | 减持 |
来源：SEC 13F 申报文件 · 截至 2026-06-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR